Publication:

5α-reductase Inhibitors and Risk of High-grade or Lethal Prostate Cancer

Thumbnail Image

Open/View Files

49930 aam nihms605361.pdf (343.58 KB)

Date

2014

Authors

Published Version

10.1001/jamainternmed.2014.1600

Journal Title

Journal ISSN

Volume Title

Publisher

American Medical Association
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Preston, Mark A., Kathryn M. Wilson, Sarah C. Markt, Rongbin Ge, Christopher Morash, Meir J. Stampfer, Massimo Loda, Edward Giovannucci, Lorelei A. Mucci, and Aria F. Olumi. 2014. “5α-Reductase Inhibitors and Risk of High-Grade or Lethal Prostate Cancer.” JAMA Internal Medicine 174 (8): 1301. https://doi.org/10.1001/jamainternmed.2014.1600.

Abstract

Description

Other Available Sources

Research Data

Keywords

Terms of Use

This article is made available under the terms and conditions applicable to Open Access Policy Articles (OAP), as set forth at Terms of Service

URI

http://nrs.harvard.edu/urn-3:HUL.InstRepos:41292549

Collections

SPH Scholarly Articles

Endorsement

Review

Supplemented By

Related Stories